Home › Funds › SSI INVESTMENT MANAGEMENT LLC › HAE
SSI INVESTMENT MANAGEMENT LLC position in HAE
HAEMONETICS CORP MASS · Health Care
SSI INVESTMENT MANAGEMENT LLC reported holding 8,272,000 shares of HAE (HAEMONETICS CORP MASS) in its Q3 2026 13F filing — a position valued at US$9.4M, representing 0.81% of its reported portfolio and ranking #31 among its reported holdings. SSI INVESTMENT MANAGEMENT LLC has disclosed HAE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SSI INVESTMENT MANAGEMENT LLC's HAE position evolved
SSI INVESTMENT MANAGEMENT LLC first disclosed a stake in HAE in Q3 2023 at 10,872,000 shares (US$9.4M). Across 13 filings, SSI INVESTMENT MANAGEMENT LLC increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 8,272,000 shares valued at US$9.4M — an increase of 1,522,000 shares quarter over quarter.. Notable position changes include a 62% trim in Q4 2023 (shares were roughly flat over the following quarter), a 38% trim in Q1 2025 (shares rose 17% over the following quarter), a 110% increase in Q1 2026 (shares rose 33% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 10.87M | $9.43M | New |
| Q4 2023 | 4.13M | $3.67M | Reduce |
| Q1 2024 | 3.57M | $3.28M | Reduce |
| Q2 2024 | 3.53M | $3.17M | Reduce |
| Q3 2024 | 4.03M | $3.71M | Add |
| Q4 2024 | 4.03M | $3.79M | Hold |
| Q1 2025 | 2.50M | $2.39M | Reduce |
| Q2 2025 | 2.50M | $2.41M | Hold |
| Q3 2025 | 2.50M | $2.44M | Hold |
| Q4 2025 | 2.50M | $2.47M | Hold |
| Q1 2026 | 5.25M | $5.00M | Add |
| Q2 2026 | 6.75M | $6.82M | Add |
| Q3 2026 | 8.27M | $9.40M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About HAE and 13F data
HAE (HAEMONETICS CORP MASS) is a Health Care company. 24 other funds we track also report a position in HAE — the largest reported positions include ARIEL INVESTMENTS, LLC (US$228.9M), River Road Asset Management, LLC (US$110.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding HAE
- ARIEL INVESTMENTS, LLC 2.17M sh · $228.88M · Q3 2026
- River Road Asset Management, LLC 1.05M sh · $110.08M · Q3 2026
More on SSI INVESTMENT MANAGEMENT LLC
FAQ
How long has SSI INVESTMENT MANAGEMENT LLC held HAE?
SSI INVESTMENT MANAGEMENT LLC has disclosed HAE holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is SSI INVESTMENT MANAGEMENT LLC's current position in HAE?
As of Q3 2026, SSI INVESTMENT MANAGEMENT LLC holds 8.27M shares of HAE (HAEMONETICS CORP MASS), valued at $9.40M, representing 0.81% of its reported portfolio and ranking #31.
Has SSI INVESTMENT MANAGEMENT LLC been buying or selling HAE?
In the latest 13F filing (Q3 2026), SSI INVESTMENT MANAGEMENT LLC increased its position in HAE.
Which other funds hold HAE?
Other major institutional holders of HAE include ARIEL INVESTMENTS, LLC, River Road Asset Management, LLC, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.